Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lithium-Induced Modulation of Proliferation and Apoptosis in an In Vitro Model of Colorectal Cancer.

International journal of molecular sciences·2025

Same author

Interleukin-1β depresses neuronal activity in the rat olfactory bulb even during odor stimulation.

PloS one·2025

Same author

Nanotechnology to Overcome Blood-Brain Barrier Permeability and Damage in Neurodegenerative Diseases.

Pharmaceutics·2025

Same author

Effect of the Anti-depressant Sertraline, the Novel Anti-seizure Drug Vinpocetine and Several Conventional Antiepileptic Drugs on the Epileptiform EEG Activity Induced by 4-Aminopyridine.

Neurochemical research·2016

Same author

Effects of Levetiracetam, Carbamazepine, Phenytoin, Valproate, Lamotrigine, Oxcarbazepine, Topiramate, Vinpocetine and Sertraline on Presynaptic Hippocampal Na(+) and Ca(2+) Channels Permeability.

Neurochemical research·2015

Same author

Brain serotonin signaling does not determine sexual preference in male mice.

PloS one·2015

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Mechanisms underlying striatal vulnerability to 3-nitropropionic acid.

Nieves Herrera-Mundo¹, María Sitges

¹Departamento de Biología Celular y Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México DF, México.

Journal of Neurochemistry

|May 19, 2010

Summary

3-nitropropionic acid (3-NPA) increases reactive oxygen species in the striatum, oxidizing dopamine (DA) into DA-quinones. These DA-quinones inhibit monoamine oxidase A, leading to altered DA metabolism and release.

More Related Videos

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

Related Experiment Videos

Last Updated: Jun 13, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease

Published on: February 14, 2012

Area of Science:

Neuroscience
Biochemistry
Toxicology

Background:

The striatum is highly vulnerable to metabolic insults.
3-nitropropionic acid (3-NPA) inhibits mitochondrial complex II.
The striatum is rich in dopamine (DA), a neurotransmitter metabolized by monoamine oxidase (MAO).

Purpose of the Study:

To investigate the effects of 3-NPA on dopamine metabolism and reactive oxygen species (ROS) generation in the striatum.
To elucidate the mechanism by which 3-NPA induces neurochemical changes in dopaminergic pathways.

Main Methods:

In vitro studies using isolated striatal nerve endings exposed to 3-NPA.
In vivo studies using animal models with motor disturbances induced by 3-NPA.
Analysis of dopamine (DA) and its metabolites (DOPAC, HVA) and reactive oxygen species (ROS).

Main Results:

3-NPA exposure increased striatal DA levels and decreased DOPAC in vitro.
Increased ROS and DA-quinone formation were observed after 3-NPA treatment.
3-NPA induced motor disturbances and altered DA metabolite levels in vivo.

Conclusions:

3-NPA-induced ROS oxidizes DA to DA-quinones in striatal nerve endings.
DA-quinones may inhibit MAO type A, disrupting DA metabolism.
Altered DA metabolism and increased DA release contribute to 3-NPA neurotoxicity.